Evaluation of NGAL TestTM on Cobas 6000

References

• Nielsen BS, Borregaard N, Bundgaard JR, Timshel S, Sehested M, Kjeldsen L. Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 1996;38:414–20.
   PubMed Web of Science ®Google Scholar
• Cowland JB, Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997;45:17–23.
   PubMed Web of Science ®Google Scholar
• Kjeldsen L, Bainton DF, Sengelov H, Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood 1994;83:799–807.
   PubMed Web of Science ®Google Scholar
• Furutani M, Arii S, Mizumoto M, Kato M, Imamura M. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method. Cancer Lett 1998;122: 209–14.
   PubMed Web of Science ®Google Scholar
• Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, Hamann S, Weimer J, Ataseven B, Darb-Esfahani S, Schem C, Mundhenke C, Khandan F, Thomssen C, Jonat W, Holzhausen HJ, von MG, Denkert C, Bauer M. Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS One 2012;7:e45826.
   Google Scholar
• Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van DW, Zuidwijk K, van der Reijden JJ, Hanemaaijer R, Griffioen G, Lamers CB, Verspaget HW. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 2007;43: 1869–76.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu L, Xiao D, Xie J, Zeng H, Wang Z, Zhang X, Niu Y, Shen Z, Shen J, Wu X, Li E. Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 2007; 60:555–61.
   PubMed Web of Science ®Google Scholar
• Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, Quinn MA, Rice GE. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 2007;120:2426–34.
   PubMed Web of Science ®Google Scholar
• Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, Vascotto C, Tell G, Salzano AM, Scaloni A, Vuttariello E, Chiappetta G, Formisano S, Leonardi A. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB- regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 2008;105:14058–63.
   PubMed Web of Science ®Google Scholar
• Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14: 2534–43.
   PubMed Web of Science ®Google Scholar
• Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002;10:1033–43.
   PubMed Web of Science ®Google Scholar
• Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005;115:610–21.
   PubMed Web of Science ®Google Scholar
• Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005;365:1231–8.
   PubMed Web of Science ®Google Scholar
• Bennett M, Dent CL, Ma Q, Dastrala S, Grenier F, Workman R, Syed H, Ali S, Barasch J, Devarajan P. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3:665–73.
   PubMed Web of Science ®Google Scholar
• Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P. Plasma neutrophil gelatinase- associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11:R127.
   Web of Science ®Google Scholar
• Christensen PH. Quantitative determination of human plasma and urine Neutrophil gelatinase associated lipocalin (NGAL) validation of an automated turbidimetric immunoassay.21st International Congress of Clinical Chemistry and Laboratory Medicine (IFCC-World Lab) in Berlin 2011.
   Google Scholar
• Lippi G, Aloe R, Storelli A, Cervellin G, Trenti T. Evaluation of NGAL Test, a fully-automated neutrophil gelatinase-associated lipocalin (NGAL) immunoassay on Beckman Coulter AU 5822. Clin Chem Lab Med 2012; 50:1581–4.
   Web of Science ®Google Scholar
• Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009;54:1012–24.
   PubMed Web of Science ®Google Scholar
• www.bioporto.com/products/bioporto_diagnostics/the_ngal_test/the_ngal_test_reagent_kit_ce_ivd. 2012.
   Google Scholar
• The NGAL Test™ Reagent Kit CE IVD. 2013. Bioporto.
   Google Scholar
• Cai L, Rubin J, Han W, Venge P, Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 2010;5:2229–35.
   PubMed Web of Science ®Google Scholar
• Kift RL, Messenger MP, Wind TC, Hepburn S, Wilson M, Thompson D, Smith MW, Sturgeon C, Lewington AJ, Selby PJ, Banks RE. A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine. Ann Clin Biochem 2013;50:236–44.
   PubMed Web of Science ®Google Scholar
• Ladinsky JL, Westring DW. The effect of anticoagulants on the volume of normal and leukemic leukocytes 2. Cancer Res 1967;27:1688–95.
   Google Scholar
• International Council for Standardization in Haematology: Expert Panel on Cytometry. Recommendations of the international council for standardization in haematology for ethylenediaminetetraacetic acid anticoagulation of blood for blood cell counting and sizing. Am J Clin Pathol 1993;100:371–2.
   Google Scholar
• Handin RI, Lux SE, Stossel TP. Blood: principles and practice of hematology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2003.
   Google Scholar
• Xu SY, Petersson CG, Carlson M, Venge P. The development of an assay for human neutrophil lipocalin (HNL) – to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994;171:245–52.
   PubMed Web of Science ®Google Scholar
• Blaser J, Triebel S, Tschesche H. A sandwich enzyme immunoassay for the determination of neutrophil lipocalin in body fluids. Clin Chim Acta 1995;235:137–45.
   Google Scholar
• Lippi G, Salvagno GL, Banfi G. Serum but not urine concentration of neutrophil gelatinase-associated lipocalin is influenced by acute leukocyte variations. Leuk Lymphoma 2012;53:1643–5.
   PubMed Web of Science ®Google Scholar
• Pedersen KR, Ravn HB, Hjortdal VE, Norregaard R, Povlsen JV. Neutrophil gelatinase-associated lipocalin (NGAL): validation of commercially available ELISA. Scand J Clin Lab Invest 2010;70:374–82.
   PubMed Web of Science ®Google Scholar